Partial Budd-Chiari syndrome associated with a hypereosinophilic syndrome;Assoziation eines segmentalen Budd-Chiari-syndroms mit einem hypereosinophilensyndrom

Zeitschrift fur Gastroenterologie

Volumn 44, Issue 2, 2006, Pages 173-177

  Becker, Valentin ^a   Lersch, C ^a   Gaa, J ^a   Schmid, R M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Budd Chiari syndrome; Hepatic veins; Hypereosinophilia; Obstruction

Indexed keywords

LIVER ENZYME;

AGED; ARTICLE; BUDD CHIARI SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIUM INJURY; HUMAN; HYPEREOSINOPHILIC SYNDROME; LIVER FUNCTION TEST; LIVER VEIN; LIVER VEIN OBSTRUCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; THROMBOSIS;

AGED; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; HYPEREOSINOPHILIC SYNDROME;

EID: 33644593409     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858769     Document Type: Article

References (28)

1. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759
2. Brito-Babapulle F. The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol 2003; 121: 203
3. Spry CJF. Idiopathic hypereosinophilic syndrome. In: Makino S, Fukuda T (eds). Eosinophils: Biological and Clinical Aspects. Boca Raton: CRC, 1992: 403
4. Owen WF, Rothenberg ME, Petersen J et al. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 1989; 170: 343
5. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992; 90: 1414
6. Luppi M, Marasca R, Morselli M et al. Clonal nature of hypereosinophilic syndrome. Blood 1994; 84: 349
7. Malbrain MLN, Van den Bergh H, Zachee P. Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: Complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality. Br J Haematol 1996; 92: 176
8. Chang HW, Leong KH, Koh DR et al. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood 1999; 93: 1651
9. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 2003; 54: 169
10. Cools J, DeAngelo DJ, Gotlib J et al. A tyrosine kinase created by fusion of the PDGFR and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201
11. Griffin JH, Leung J, Bruner RJ et al. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci USA 2003; 100: 7830
12. Gotlib J, Cools J, Malone JM III et al. The FIP1L1-PDGFR fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 2004; 103 (8): 2879-2891
13. Klion AD, Noel P, Akin C et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003; 101: 4660
14. Simon HU, Yousefi S, Dommann-Scherrer CC et al. Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996; 183: 071
15. Kitano K, Ichikawa N, Mahbub B et al. Eosinophilia associated with proliferation of CD(3+)4-(8-) alpha beta+ T cells with chromosome 16 anomalies. Br J Haematol 1996; 92: 315
16. Roufosse F, Schandene L, Sibille C et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol 2000; 109: 540
17. Kay AB, Klion AD. Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome. Immunol Allergy Clin North Am 2004; 24: 645
18. Plotz SG, Simon HU, Darsow U et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 2003; 349 (24): 2334-2339
19. Fauci AS, Harley JB, Roberts WC et al. NIH Conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982; 97: 78
20. Chaine G, Davies J, Kohner EM et al. Ophthalmologic abnormalities in the hypereosinophilic syndrome. Ophthalmology 1982; 89: 1348
21. Butterfield JH, Gleich GJ. Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med 1994; 121: 648
22. Desreumaux P, Janin A, Dubucquoi S et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 1993; 82: 1553
23. Moore PM, Harley JB, Fauci AS. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 1985; 102: 109
24. Weller PF. The idiopathic hypereosinophilic syndrome. Arch Dermatol 1996; 132: 583
25. Zylberberg H, Valla D, Viguie F et al. Budd-Chiari-syndrom associated with 5 q deletion and hypereosinophilia. J Clin Gastroenterol 1996; 23 (1): 66-68
26. Chusid MJ, Dale DC, West BC et al. The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975; 54: 1
27. Spry CJ, Davies J, Tai PC et al. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 1983; 52: 1
28. Janssen H, Garcia-Pagan JC, Elias E et al. Budd Chiari-syndrom: a review by an expert panel. J Hepatol 2003; 38: 364-371